Michael A. Ueberall

823 total citations
28 papers, 588 citations indexed

About

Michael A. Ueberall is a scholar working on Pharmacology, Physiology and Anesthesiology and Pain Medicine. According to data from OpenAlex, Michael A. Ueberall has authored 28 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 10 papers in Physiology and 9 papers in Anesthesiology and Pain Medicine. Recurrent topics in Michael A. Ueberall's work include Pain Management and Opioid Use (9 papers), Pain Mechanisms and Treatments (8 papers) and Musculoskeletal pain and rehabilitation (6 papers). Michael A. Ueberall is often cited by papers focused on Pain Management and Opioid Use (9 papers), Pain Mechanisms and Treatments (8 papers) and Musculoskeletal pain and rehabilitation (6 papers). Michael A. Ueberall collaborates with scholars based in Germany, Austria and Switzerland. Michael A. Ueberall's co-authors include Gerhard Mueller-Schwefe, Dieter Wenzel, Ute Essner, Heike Beneš, Ralf Kohnen, Thorsten Langer, W Meier, Holger Hertzberg, W. Huk and Jörn D. Beck and has published in prestigious journals such as Neurology, Diabetes and SLEEP.

In The Last Decade

Michael A. Ueberall

27 papers receiving 553 citations

Peers

Michael A. Ueberall

PMH

PHYSI

PPCH

PHARM

PHEOH

Mahmoud Slim Canada

César Margarit Spain

Andrew Clair United States

T.K. Murphy United States

Vitaly Gordin United States

Michael S. Leong United States

Sarah Youssof United States

Errol Gould United States

Lindy J. Roberts Australia

Sanjeet Narang United States

Mahmoud Slim Canada

Michael A. Ueberall

367 ×1.8

PMH

112 ×0.8

PHYSI

65 ×0.5

PPCH

203 ×1.5

PHARM

51 ×0.5

PHEOH

Citations per year, relative to Michael A. Ueberall Michael A. Ueberall (= 1×) peers Mahmoud Slim

Countries citing papers authored by Michael A. Ueberall

Since Specialization

Citations

This map shows the geographic impact of Michael A. Ueberall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Ueberall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Ueberall more than expected).

Fields of papers citing papers by Michael A. Ueberall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Ueberall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Ueberall. The network helps show where Michael A. Ueberall may publish in the future.

Co-authorship network of co-authors of Michael A. Ueberall

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Ueberall. A scholar is included among the top collaborators of Michael A. Ueberall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Ueberall. Michael A. Ueberall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ueberall, Michael A., et al.. (2024). 1892-LB: Impact of Ongoing Treatment with High Concentration Capsaicin Topical System on Affective Distress and Quality of Life in Patients with Painful Diabetic Neuropathy—A Retrospective Cohort Study. Diabetes. 73(Supplement_1). 1 indexed citations

Ueberall, Michael A., et al.. (2022). Effectiveness and Tolerability of Dronabinol Use in Patients with Chronic Pain: A Retrospective Analysis of 12-Week Open-Label Real-World Data Provided by the German Pain e-Registry. Pain Medicine. 23(8). 1409–1422. 6 indexed citations

Henrotin, Yves, et al.. (2022). Combination of Enzymes and Rutin to Manage Osteoarthritis Symptoms: Lessons from a Narrative Review of the Literature. Rheumatology and Therapy. 9(5). 1305–1327. 9 indexed citations

Ueberall, Michael A., et al.. (2021). Prevalence of drug-induced constipation and severity of associated biopsychosocial effects in patients with nonmalignant pain: a cross-sectional review of depersonalized data from the German Pain e-Registry. Current Medical Research and Opinion. 38(1). 101–114. 3 indexed citations

Ueberall, Michael A., et al.. (2021). Effectiveness, Safety, and Tolerability of Nabiximols Oromucosal Spray vs Typical Oral Long-Acting Opioid Analgesics in Patients with Severe Neuropathic Back Pain: Analysis of 6-Month Real-World Data from the German Pain e-Registry. Pain Medicine. 23(4). 745–760. 8 indexed citations

Ueberall, Michael A., Ute Essner, & Gerhard Mueller-Schwefe. (2019). <p>Effectiveness and tolerability of THC:CBD oromucosal spray as add-on measure in patients with severe chronic pain: analysis of 12-week open-label real-world data provided by the German Pain e-Registry</p>. Journal of Pain Research. Volume 12. 1577–1604. 48 indexed citations

Ueberall, Michael A., et al.. (2016). Quality of life under oxycodone/naloxone, oxycodone, or morphine treatment for chronic low back pain in routine clinical practice. International Journal of General Medicine. 9. 39–39. 8 indexed citations

Ueberall, Michael A., Gerhard Mueller-Schwefe, R. Wigand, & Ute Essner. (2016). Efficacy, tolerability, and safety of an oral enzyme combination vs diclofenac in osteoarthritis of the knee: results of an individual patient-level pooled reanalysis of data from six randomized controlled trials. Journal of Pain Research. Volume 9. 941–961. 11 indexed citations

Ueberall, Michael A. & Gerhard Mueller-Schwefe. (2016). Efficacy and tolerability balance of oxycodone/naloxone and tapentadol in chronic low back pain with a neuropathic component: a blinded end point analysis of randomly selected routine data from 12-week prospective open-label observations. Journal of Pain Research. Volume 9. 1001–1020. 17 indexed citations

10.

Ueberall, Michael A. & Gerhard Mueller-Schwefe. (2015). Development of opioid-induced constipation: post hoc analysis of data from a 12-week prospective, open-label, blinded-endpoint streamlined study in low-back pain patients treated with prolonged-release WHO step III opioids. Journal of Pain Research. 8. 459–459. 9 indexed citations

11.

Ueberall, Michael A., Gerhard Mueller-Schwefe, & B Terhaag. (2011). Efficacy and tolerability of flupirtine in subacute/ chronic musculoskeletal pain – results of a patient level, pooled re-analysis of randomized, double-blind, controlled trials. International Journal of Clinical Pharmacology and Therapeutics. 49(11). 637–647. 13 indexed citations

12.

Weber, Janet L., Marcus Schley, Helmut Gerber, et al.. (2009). Tetrahydrocannabinol (Delta 9-THC) Treatment in Chronic Central Neuropathic Pain and Fibromyalgia Patients: Results of a Multicenter Survey. Anesthesiology Research and Practice. 2009. 1–9. 47 indexed citations

13.

Mueller-Schwefe, Gerhard & Michael A. Ueberall. (2006). 704 OXYCODONE IN DAILY PRACTICE — FULFILLING UNMEET NEEDS AND ADRESSING INDIVIDUAL EXPECTATIONS OF PATIENTS SUFFERING FROM SEVERE CHRONIC PAIN. European Journal of Pain. 10(S1). 1 indexed citations

14.

Ueberall, Michael A. & Gerhard Mueller-Schwefe. (2006). 705 INDIVIUDAL TREATMENT TARGETS IN CHRONIC PAIN MANAGEMENT. European Journal of Pain. 10(S1). 1 indexed citations

15.

Steinhoff, Bernhard J., Michael A. Ueberall, H. Siemes, et al.. (2005). The LAM-SAFE Study: Lamotrigine versus carbamazepine or valproic acid in newly diagnosed focal and generalised epilepsies in adolescents and adults. Seizure. 14(8). 597–605. 42 indexed citations

16.

Beneš, Heike, et al.. (2004). Long-term Safety and Efficacy of Cabergoline for the Treatment of Idiopathic Restless Legs Syndrome: Results from an Open-Label 6-Month Clinical Trial. SLEEP. 27(4). 674–682. 53 indexed citations

17.

Ueberall, Michael A.. (2001). Normal growth during lamotrigine monotherapy in pediatric epilepsy patients — a prospective evaluation of 103 children and adolescents. Epilepsy Research. 46(1). 63–67. 9 indexed citations

18.

Ueberall, Michael A., et al.. (1998). Epidural and pericranial abscesses complicating frontal sinusitis in a comatose child. Pediatric Neurology. 19(5). 385–387. 3 indexed citations

19.

Hertzberg, Holger, W. Huk, Michael A. Ueberall, et al.. (1997). CNS late effects after ALL therapy in childhood. Part I: Neuroradiological findings in long-term survivors of childhood ALL—an evaluation of the interferences between morphology and neuropsychological performance. Medical and Pediatric Oncology. 28(6). 387–400. 80 indexed citations

20.

Ueberall, Michael A., Holger Hertzberg, Thorsten Langer, et al.. (1996). Quantitative EEG in long-term survivors of acute lymphoblastic leukemia. Pediatric Neurology. 15(4). 293–298. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact